Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Whitehawk Therapeutics, Inc.
ViroMissile, Inc.
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Clasp Therapeutics, Inc.
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Seagen Inc.
Novartis
Seagen Inc.
University Health Network, Toronto
Chongqing Precision Biotech Co., Ltd
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Novartis
Sichuan Enray Pharmaceutical Sciences Company
Novita Pharmaceuticals, Inc.
Anhui Provincial Hospital
Lyell Immunopharma, Inc.
Compugen Ltd
Monopar Therapeutics
Monopar Therapeutics
Revolution Medicines, Inc.
Tomsk National Research Medical Center of the Russian Academy of Sciences
Rutgers, The State University of New Jersey
Checkpoint Therapeutics, Inc.
Compugen Ltd
Vincerx Pharma, Inc.
Revolution Medicines, Inc.
Pfizer
Celldex Therapeutics
Institut Paoli-Calmettes
STCube, Inc.
Lebanese University
Corvus Pharmaceuticals, Inc.
SCRI Development Innovations, LLC
Fate Therapeutics
Candel Therapeutics, Inc.
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
Prelude Therapeutics
Quadriga Biosciences, Inc.
Revolution Medicines, Inc.
Imperial College London
Pfizer